1 |
Xu W, Yu H, Zhao R, Liang Y. Investigation of mitochondrial targeting ability of sydnones and sydnonimines and mitochondria-targeted delivery of celecoxib. Bioorg Med Chem Lett 2023;81:129129. [PMID: 36634752 DOI: 10.1016/j.bmcl.2023.129129] [Reference Citation Analysis]
|
2 |
Zhang R, Gao J, Zhao G, Zhou L, Kong F, Jiang T, Jiang H. Tetrazine bioorthogonal chemistry makes nanotechnology a powerful toolbox for biological applications. Nanoscale 2023;15:461-9. [PMID: 36533721 DOI: 10.1039/d2nr06056f] [Reference Citation Analysis]
|
3 |
Nakahara H, Hagimori M, Mukai T, Shibata O. Interplay of long-chain tetrazine derivatives and biomembrane components at the air–water interface. Biophysics Rev 2022;3:021303. [DOI: 10.1063/5.0083352] [Reference Citation Analysis]
|
4 |
Kannaka K, Sano K, Munekane M, Yamasaki T, Hagimori M, Mukai T. Enhanced Therapeutic Effect of Liposomal Doxorubicin via Bio-Orthogonal Chemical Reactions in Tumors. Mol Pharmaceutics. [DOI: 10.1021/acs.molpharmaceut.1c00936] [Reference Citation Analysis]
|
5 |
Qualls ML, Sagar R, Lou J, Best MD. Demolish and Rebuild: Controlling Lipid Self-Assembly toward Triggered Release and Artificial Cells. J Phys Chem B 2021;125:12918-33. [PMID: 34792362 DOI: 10.1021/acs.jpcb.1c07406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|